News
Pieris AG | Wacker Validates Scalability of Anticalin(R) Pr... |...
www.investegate.co.uk
Andreas Hohlbaum Ph.D., Chief Technology Officer of Pieris, stated: "Pieris has long-established expertise in small scale expression of ...
Pieris Reaches Key Milestones Under the Collaboration Agreement With...
www.europapress.es
For further information, please contact: Pieris AG. Dr Andreas Hohlbaum, Director of Science & PD, Phone +49-(0) Notes to ...
WACKER bestätigt Skalierbarkeit der Anticalin®-Produktion mit...
www.ots.at
Österreichs größtes Portal für multimediale Presseinformationen
Crystallographic analysis of Anticalin® targeting CTLA-4 confirms...
www.finanznachrichten.de
ENDS For further information, please contact: Pieris AG Dr Andreas Hohlbaum, Dir. of Science & Preclin. Dev., Phone +49 (0)
sortiert nach Relevanz / Datum